|
Thermo Fisher
allophycocyanin anti mcd8α Allophycocyanin Anti Mcd8α, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti-mcd8%CE%B1/Streptavidin/pmc02211925-42-63-68 Average 99 stars, based on 1 article reviews
allophycocyanin anti mcd8α - by Bioz Stars,
2026-10
99/100 stars
|
Buy from Supplier |
|
Becton Dickinson
anti-mcd8 α ![]() Anti Mcd8 α, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti-mcd8%CE%B1/anti+mcd8/pmc03201985-69-61-63 Average 90 stars, based on 1 article reviews
anti-mcd8 α - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Gastroenterology
Article Title: Gut Homing Receptors on CD8 T Cells Are Retinoic Acid Dependent and Not Maintained by Liver Dendritic or Stellate Cells
doi: 10.1053/j.gastro.2009.02.046
Figure Lengend Snippet: Plasticity of CCR9 and α4β7 expression in mice. (A and B) Expression of gut homing molecules on murine CD8 T cells reactivated with or without ATRA. Naïve TCR-transgenic (P14) CD8 T cells were activated with antigen-loaded spleen DC and either with or without ATRA (first stimulation). T cells were then reactivated under the same or the opposite conditions (second stimulation). (C and D) T cells reactivated with or without ATRA were differentially labelled (red or green) and injected into congenic mice to analyze their in vivo migration to different tissues. (A and B) Representative FACS plots are shown with percentage expression and mean channel fluorescence in parentheses. (C and D) Graphs show the mean ± range. *P < .01.
Article Snippet: Anti-mCCR9 (clone 5F2) and anti-hα4β7 (ACT-1; 15 µg/mL) (M. Briskin Millennium Pharm, Inc, Cambridge, MA), anti-hCD3-RPE/Cy7 (UCHT1; 1:10; Coulter, London, UK), anti-hCD11a-FITC (MEM-25; 8 µg/mL; Caltag, Buckingham, UK), anti-hCD45RA-PE/Cy5 (HI30; 1:20 [vol/vol]; Serotec, Oxford, UK), anti-hβ7-PE/Cy5 (FIB504; 1:20 [vol/vol]; BD, Oxford, UK), anti-hCD8-APC/Cy7 (SK7; 1:10 [vol/vol]; BD, Oxford, UK), anti-hCCR9-APC (FAB1791A; 2.5 µg/mL; R&D Systems, Abingdon, UK), anti-mα4β7 (DATK32; BD), and
Techniques: Expressing, Transgenic Assay, Injection, In Vivo, Migration, Fluorescence